Exact Mass: 414.07443520000004

Exact Mass Matches: 414.07443520000004

Found 28 metabolites which its exact mass value is equals to given mass value 414.07443520000004, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

(7R)-7-(5-Carboxy-5-oxopentanoyl)aminocephalosporinate

(6R,7R)-3-[(acetyloxy)methyl]-7-[(5-carboxy-1-hydroxy-5-oxopentylidene)amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

C16H18N2O9S (414.07329780000003)

This compound belongs to the family of N-acyl-alpha Amino Acids and Derivatives. These are compounds containing an alpha amino acid which bears an acyl group at his terminal nitrogen atom.

Vorasidenib

C14H13ClF6N6 (414.079436)

C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C137826 - Isocitrate Dehydrogenase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent Vorasidenib (AG-881) is an orally available, brain penetrant second-generation dual mutant isocitrate dehydrogenases 1 and 2 (mIDH1/2) inhibitor. Vorasidenib (AG-881) exhibits nanomolar inhibition of (D)-2-hydroxyglutarate (D-2-HG), and the IC50 ranges of 0.04~22 nM against IDH1 R132C, IDH1 R132G, IDH1 R132H and IDH1 R132S and 7~14 nM against IDH2 R140Q and 130 nM against IDH2 R172K[1][2].

Talniflumate

3-oxo-1,3-Dihydro-2-benzofuran-1-yl 2-{[3-(trifluoromethyl)phenyl]amino}pyridine-3-carboxylic acid

C21H13F3N2O4 (414.08273740000004)

C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic

13-O-methyl xestoquinol sulfate

C21H18O7S (414.0773198)

Cys Cys Cys Ser

(2S)-2-[(2R)-2-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanamido]-3-sulfanylpropanamido]-3-hydroxypropanoic acid

C12H22N4O6S3 (414.0701432)

Cys Cys Ser Cys

(2R)-2-[(2S)-2-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanamido]-3-hydroxypropanamido]-3-sulfanylpropanoic acid

C12H22N4O6S3 (414.0701432)

Cys Ser Cys Cys

(2R)-2-[(2R)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-hydroxypropanamido]-3-sulfanylpropanamido]-3-sulfanylpropanoic acid

C12H22N4O6S3 (414.0701432)

Ser Cys Cys Cys

(2R)-2-[(2R)-2-[(2R)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-sulfanylpropanamido]-3-sulfanylpropanamido]-3-sulfanylpropanoic acid

C12H22N4O6S3 (414.0701432)

(3-METHOXYPROPYL)TRIPHENYLPHOSPHONIUM BROMIDE

C22H24BrOP (414.0748044)

Deshydroxy bicalutamide

C18H14F4N2O3S (414.0661222)

2-Methylpropyl N-(2-chloropyridine-3-sulfonyl)-N-(3-Methoxy-5-Methylpyrazin-2-yl)carbamate

C16H19ClN4O5S (414.0764634)

[2-(5-Mercapto-[1,3,4]thiadiazol-2-ylcarbamoyl)-1-phenyl-ethyl]-carbamic acid benzyl ester

C19H18N4O3S2 (414.08202780000005)

D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D061965 - Matrix Metalloproteinase Inhibitors

Talniflumate

C21H13F3N2O4 (414.08273740000004)

C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic

2-O-sinapoyl-D-glucarate(2-)

C17H18O12-2 (414.0798228)

4-methylumbelliferyl-phospho-beta-D-glucopyranoside

C17H19O10P-2 (414.0715804)

(4aR,12aR)-1,4a,10,11,12a-pentahydroxy-8-methoxy-3,12-dioxo-4,5-dihydrotetracene-2-carboxamide

C20H16NO9- (414.0825026)

Clorobiocic acid

C21H17ClNO6- (414.07443520000004)

2-[(5-Bromo-1,3-benzoxazol-2-yl)amino]-5-spiro[1,6,7,8-tetrahydroquinazoline-4,1-cyclopentane]one

C19H19BrN4O2 (414.06912939999995)

1-[[(4-Ethoxyanilino)-sulfanylidenemethyl]amino]-3-[3-(trifluoromethyl)phenyl]thiourea

C17H17F3N4OS2 (414.07958279999997)

N-(5-methyl-3-isoxazolyl)-2-[(6-methyl-4-oxo-3-phenyl-6,7-dihydrothieno[3,2-d]pyrimidin-2-yl)thio]acetamide

C19H18N4O3S2 (414.08202780000005)

N-(2,4,6-trinitrophenyl)-betaAlaGlyGly

C13H14N6O10 (414.07713839999997)

crotonyl-AMP(1-)

C14H17N5O8P- (414.0814712)

6-[[6-[(E)-2-carboxyethenyl]-4-methoxy-1,3-benzodioxol-5-yl]oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid

C17H18O12 (414.0798228)

(7R)-7-(5-Carboxy-5-oxopentanoyl)aminocephalosporinate

(7R)-7-(5-carboxy-5-oxopentanamido)cephalosporanic acid

C16H18N2O9S (414.07329780000003)

A cephalosporin having an acetoxy group at the 3-position and a 5-carboxy-5-oxopentanamido group at the 7-position.

Clozapine N-oxide (dihydrochloride)

C18H21Cl3N4O (414.0780866)

Clozapine N-oxide dihydrochloride is a major metabolite of Clozapine and a human muscarinic designer receptors (DREADDs) agonist. Clozapine N-oxide dihydrochloride activates the DREADD receptor hM3Dq and hM4Di. Clozapine N-oxide dihydrochloride can cross the blood-brain barrier[1][2][3][4]. Clozapine is a potent dopamine antagonist and also a potent and selective muscarinic M4 receptor (EC50=11 nM) agonist[5][6].